Skip to main content

PALISADE CAPITAL MANAGEMENT, LP

Position in CSTL — Castle Biosciences Inc

CIK 1009006 FORT LEE, NJ

Position in CSTL

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,531,554
-$7,624,398 QoQ
Shares Held
231,931
-56.7% QoQ
Ownership
0.759%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#33
of 176 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 88% Shared 0% None 12%

Common Shares in CSTL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $66,109,829 across 6 Diagnostics & Research names. CSTL ranks #5 (8.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 CSTL
Castle Biosciences Inc
This page
231,931 $5,531,554

All Filings in CSTL

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,531,554 231,931
2026-03-31 $13,155,952 535,884
2025-12-31 $22,086,525 567,777
2025-09-30 $14,542,197 638,656
2025-06-30 $11,743,868 575,116
2025-03-31 $9,809,159 489,968
2024-12-31 $13,416,729 503,442
2024-09-30 $14,326,080 502,317
2024-06-30 $11,711,693 537,974
2024-03-31 $12,119,749 547,167
2023-12-31 $11,634,533 539,135
2023-09-30 $10,172,188 602,261
2023-06-30 $8,262,238 602,204
2023-03-31 $13,109,848 577,018
2022-12-31 $12,972,776 551,095
2022-09-30 $15,124,939 579,944
2022-06-30 $12,707,579 578,933
2022-03-31 $18,358,147 409,232
2021-12-31 $15,109,145 352,441